Christian Albers
Business Development Manager, Pharmaceuticals Market, Bruker Daltonics
False
QTOF: Quick Off the Mark for Oligonucleotide Analysis
November 15, 2023
Experts from Axolabs GmbH and Bruker Daltonics explain the benefits behind mass spectrometry for oligonucleotides in drug discovery
4 min read
Newsletters
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
